Monthly Cost Breakdown: Wegovy vs Mounjaro Investment
What's Better Wegovy or Mounjaro: Monthly Cost Structure Comparison
When evaluating what's better between Wegovy or Mounjaro, the monthly cost structure differs significantly between these prescription-only medicines. Wegovy follows a 16-week dose escalation requiring five different pen strengths, whilst Mounjaro uses a similar escalation pattern with its own pricing structure. Understanding monthly costs helps you plan your weight management journey effectively alongside a reduced-calorie diet and increased physical activity.
The key difference lies not just in monthly pricing but in storage convenience—Wegovy maintains stability for 6 weeks at room temperature compared to Mounjaro's 21 days. This practical advantage can reduce waste if you travel frequently or experience delivery delays, ultimately affecting your monthly cost calculations.
Wegovy Monthly Cost Breakdown: What's Better Value Wegovy or Mounjaro
Wegovy's monthly costs follow a structured escalation over 16 weeks before reaching maintenance pricing. Month 1 costs £79.99 (0.25mg starter dose), Month 2 increases to £94.99 (0.5mg), Month 3 reaches £99.99 (1mg), and Month 4 costs £139.99 (1.7mg). From Month 5 onwards, the maintenance dose costs £209.99 monthly, creating predictable budgeting for long-term treatment.
Our bundle options provide convenience rather than savings—the Getting Started Intro Duo (0.25mg & 0.5mg) costs £169.99 for two months' supply, whilst the Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 to reach these final prices.
Clinical Evidence: What's Better Wegovy or Mounjaro for Long-term Investment
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained weight management at 2 years, supporting long-term monthly investment decisions.
The SELECT trial revealed a 20% reduction in major cardiovascular events, potentially offsetting monthly medication costs through improved health outcomes. However, STEP 1 extension data showed patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that monthly costs represent ongoing investment rather than short-term expense.
How Wegovy Works: Understanding What's Better Wegovy or Mounjaro Mechanisms
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. This mechanism reduces appetite and promotes feeling of fullness after smaller meals, potentially reducing food cravings by working on brain appetite centres. Unlike Mounjaro's dual GIP + GLP-1 approach, Wegovy focuses specifically on GLP-1 pathways. The once-weekly injection uses Novo Nordisk's FlexTouch pen technology for convenient self-administration. Understanding these mechanisms helps justify monthly costs as investment in appetite regulation rather than temporary intervention.
Ordering Process: What's Better Wegovy or Mounjaro Accessibility
EverydayMeds streamlines access to both Wegovy and Mounjaro through our 3-minute online clinical assessment. Our GPhC-registered prescribers (#9012878) review applications within 3 working days (24-hour express option available). Once approved, we dispatch via next-day cold-chain delivery maintaining 2-8°C temperature control. Both medications require clinical assessment to ensure BMI ≥30 or BMI ≥27 with weight-related comorbidities. This consistent process means monthly reordering becomes straightforward regardless of which medication your prescriber recommends.
Storage and Practical Considerations: What's Better Wegovy or Mounjaro Convenience
Wegovy requires refrigeration at 2-8°C before first use but tolerates 6 weeks at room temperature below 30°C once removed from the fridge. This storage advantage over Mounjaro's 21-day room temperature limit reduces potential wastage costs. The FlexTouch pen delivers precise doses during the mandatory escalation schedule. Dose escalation cannot be skipped, making monthly cost progression predictable. The 7.2mg higher dose recently approved by MHRA (6 January 2026) isn't yet available at EverydayMeds but may provide future options.
Annual Cost Planning: What's Better Wegovy or Mounjaro for Budget Management
Calculating annual costs helps determine what's better between Wegovy or Mounjaro for your financial planning. Wegovy's first year costs approximately £1,899 (including escalation months), whilst maintenance years cost around £2,520 assuming 12 months at £209.99 monthly. These figures include our discount codes applied at checkout.
Both medications represent significant annual investment, but the potential reduction in obesity-related healthcare costs may offset medication expenses over time. The SELECT trial's cardiovascular benefits suggest long-term value beyond weight management alone, making annual cost comparison more complex than simple price comparison.
Making Your Decision: What's Better Wegovy or Mounjaro Investment Choice
Your prescriber will help determine what's better between Wegovy or Mounjaro based on your clinical profile, lifestyle factors, and cost considerations. Both are prescription-only medicines available through EverydayMeds with identical assessment and delivery processes. Monthly costs remain consistent once you reach maintenance dosing, making long-term budgeting straightforward. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, using code FIRST40 for new customers or DOSE25 for returning patients. Our clinical team provides ongoing support throughout your weight management journey, ensuring optimal value from your monthly investment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
